Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]

Core Evidence Pub Date : 2014-03-14 DOI:10.2147/CE.S63964

T. Fischell

引用次数: 0

查看原文本刊更多论文

依替巴肽:其在急性冠状动脉综合征治疗中的作用的证据[勘误]

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Core Evidence PHARMACOLOGY & PHARMACY-

自引率

0.00%

发文量

期刊介绍： Core Evidence evaluates the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to postlaunch. The focus of each review is to evaluate the case for a new drug or class in outcome terms in specific indications and patient groups The emerging evidence on new drugs is reviewed at key stages of development and evaluated against unmet needs